The Art and Science of Anxiolysis and Sedation in 2015 and Beyond – Nitrous Oxide and Oral Sedation
David Donaldson BDS, FDSRCS, MDS, FADSA, FACD, FAAOP, FICD
Fred C. Quarnstrom DDS, FADSA, FAGD, FICD, FACD, CDC
Mark Donaldson BSP, PHARM D, FASHP, FACHE
Friday, February 20 – Sunday, February 22, 2015
Center for Urban Horitculture – NHS Hall
3501 NE 41st Street
Seattle, Washington 98105
Saturday and Sunday:
Health Sciences Building
University of Washington
Turner Auditorium, Room D-209
Seattle, Washington 98195
This course is applicable for all dental professionals interested in providing minimal sedation in their office.
Registration and Continental Breakfast: 8:00am – 8:30am
Course: 8:30am – 4:30pm
Until February 18, 2015 (after, $25 more)
$399/Dentist per day
$249/Staff per day
$359/Current Dental Alumni Member per day
This course is designed to satisfy requirements for Washington State (WAC 246-817-701 through 790), Oregon State (§818-026), Idaho State (§19.01.01.060.01), and Alberta (Modality 3 Standards for the Use of Sedation in Non-Hospital Dental Practice). Actual number of hours required by each state can vary.
CREDITS: 7 hours per day
* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.
Dental practitioners, hygienists and team members interested in providing safe and effective minimal sedation for their patients should come to this course. For those practitioners already familiar with these modalities, this course represents the most comprehensive and up-to-date approaches for ensuring successful outcomes for you, your team, and your patients. Our experienced faculty offer a multimedia approach to education, including relevant and useful pharmacology, and have taught over 20,000 dentists how to safely sedate dental patients. Whether you are interested in getting started, or have been using these tools for years, we will provide practical information taught by top professionals in this field.
Instruction in all aspects of inhalational analgesia and oral conscious sedation, including effective methods in dealing with anxiety control in general practice will be discussed. Participants will learn various techniques and protocols designed to achieve certification in nitrous oxide/oxygen sedation as well as competency in providing oral anxiolysis. A patient-centered approach to care is emphasized with lectures on appropriate patient selection, medication selection, necessary monitoring and emergency management.
Friday, February 20th
- Comparison of Techniques – Why Oral Sedation?
- Pharmacology of Oral Sedatives
- Oral Sedation Techniques, Protocols, Case Studies
- The Ideal Appointment: Putting it All Together
- What’s in Your Emergency Kit
- When Sedation is Not Enough: Local Anesthesia Update
- Oral Sedation “Politics”, Rules and Regulations
Saturday, February 21st
- From Inhalational to Intravenous Sedation
- Pharmacology 101
- Pain Theory
- Nitrous Oxide Equipment
- Applied Physiology & Anatomy of Respiration
- Incremental Induction techniques
- First Clinic
- Drug Interactions
Sunday, February 22nd
- Medical Emergencies
- Nitrous Oxide and Oxygen Pharmacology
- Second Demonstration – Rapid Induction technique
- Second Clinic
- Post-operative Analgesics
- Third Demonstration – Contemporary technique, BMV & AED
- Third Clinic
- Installation of Systems
- Contamination and Scavenging
- Nitrous Oxide Complications / Contraindications
As a result of attending this course, you will be able to:
- Provide safe and effective minimal sedation using oral and inhalational techniques.
- Discuss the pharmacologic agents available for oral sedation and understand their optimal use in dentistry.
- Modify dental treatment in relation to overall therapeutic regimen and recognize and manage potential emergencies.
- Examine your emergency kit and use it comfortably in an urgent situation.
- Understand why some drugs work and some don’t for postoperative dental pain.
- Understand how drugs are metabolized – learn how to manage and avoid drug interactions.
David Donaldson obtained his dental degree at St. Andrews University in Scotland, and completed his Fellowship in Dental Surgery through the Royal College of Surgeons in Edinburgh. Upon earning his Master’s degree in Restorative Dentistry at Dundee University, he assumed the position of Director of Pain and Anxiety Control in the Faculty of Dentistry at the University of British Columbia.
Since then he has held many positions, including Assistant Dean, Chairman of Curriculum, member of the University Senate and Head of three departments. His teaching and research interests have mainly been in anesthesia and pain control, and in recognition of his achievements he was elected to the Fellowship in the American Dental Society of Anesthesia. In 1994, Dr. Donaldson was appointed as a Diplomat of the American Academy of Pain Management. His scientific publications and presentations are extensive, and he has co-authored several textbooks. He has presented over 1000 continuing education courses for dentists, dental hygienists, and physicians.
Fred Quarnstrom is a Dental Anesthesiologist who received his DDS degree from the University of Washington School of Dentistry, and was a postgraduate resident in anesthesiology at Washington Hospital Center in Washington, D.C. He is a member of the American Dental Society of Anesthesiology, the International College of Dentistry, a Fellow in the Academy of General Dentistry, and a Diplomat of the American Dental Board of Anesthesiology.
Currently, Dr. Quarnstrom is an Affiliate Assistant Professor at the University of Washington School of Dentistry, and maintains a general practice in Seattle, Washington. He has lectured extensively on nitrous oxide/oxygen analgesia and was a pioneer in establishing the effectiveness of benzodiazepines for use in oral sedation.
Mark Donaldson received his B.Sc.(Pharm.) from the University of British Columbia, and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and is the current Director of Pharmaceutical Services at the Kalispell Regional Medical Center in Kalispell, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has been a primary author and investigator for the National Institutes of Health (NIH) Consensus Development Committee to define the guidelines for enteral sedation in the United States, as well as an invited expert to compose a whitepaper on Enteral Conscious Sedation for the Academy of General Dentistry (AGD). Dr. Donaldson is a reviewer for the American Journal of Health-System Pharmacy and General Dentistry, and sits on the Editorial Board for the Journal of the American Dental Association (JADA).
The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The University of Washington is a member of the Association for Continuing Dental Education.
University of Washington designates this activity for 7 continuing education credits.